REVMED Wins 2025 Korea Trusted Innovation Award for Technological Excellence

South Korean biomedical company REV-MED Co., Ltd. (CEO Shin Bong-geun) has been honored with the Next-Generation Regenerative Medicine Technology Innovation Award at the 2025 Korea Trusted Innovation Awards, jointly hosted by JoongAng Ilbo and Forbes Korea. The recognition highlights REV-MED's efforts to address long-standing challenges in regenerative medicine-namely, inconsistencies in clinical…